Key Market Indicators
**Latvian Vaccination Coverage Hits 100% for One-Year-Olds in 2023** Latvian vaccination coverage for children aged one year old reached a remarkable 100% in 2023, up from 99% in 2022. This 1% increase marks a significant achievement in public health. Since 1997, the Latvian market has seen a consistent rise in vaccination rates, averaging an annual increase of 0.8%. **Vaccine Imports Projected to Rise** Latvia's vaccine imports are projected to reach approximately $17.7 million by 2028, up from $16.6 million in 2023. This represents a compound annual growth rate (CAGR) of 0.9%. Since 1999, the demand for vaccines in Latvia has grown steadily, with an average annual increase of 1.4%. **Growth in Vaccine Exports** Latvian vaccine exports are expected to hit around $2.1 million by 2028, up from $1.9 million in 2023. This growth reflects an average annual increase of 1.9%. Over the years, the country has seen a robust rise in vaccine supply, with an average yearly growth rate of 3.6% since 1999. In 2023, Latvia ranked 39th in vaccine exports, with Romania surpassing it at the same value of $1.9 million. Belgium, the United Kingdom, and France held the second, third, and fourth spots, respectively, in the global ranking.
